Metraipolis › archive › dc_7f7d7895136f
Dominant TET2 mutations predict adverse prognosis in cytogenetically normal acute myeloid leukemia patients — Europe PMC PMID:41561754
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41561754
- DOI
- 10.3389/fonc.2025.1730830
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T01:25:35.504Z
- SHA-256 of the archived text
ce844c8d7c3f663ec5e34fd40861692ca30294ccbd1d5aa35dd12a9915aea17e- Stable URL of this page
https://metraipolis.com/documento/dc_7f7d7895136f
How to cite
Dominant TET2 mutations predict adverse prognosis in cytogenetically normal acute myeloid leukemia patients — Europe PMC PMID:41561754 — Europe PMC (en), https://europepmc.org/article/MED/41561754 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7f7d7895136f (Metraipolis archive dc_7f7d7895136f, sha256 ce844c8d7c3f663ec5e34fd40861692ca30294ccbd1d5aa35dd12a9915aea17e)
BibTeX
@misc{dc7f7d7895136f,
title = {Dominant TET2 mutations predict adverse prognosis in cytogenetically normal acute myeloid leukemia patients — Europe PMC PMID:41561754},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41561754},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7f7d7895136f; sha256 ce844c8d7c3f663ec5e34fd40861692ca30294ccbd1d5aa35dd12a9915aea17e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41561754. Agents can read the archived copy with the MCP tool read_document.